Other studies have demonstrated that treatment with angiotensin-converting enzyme (ACE) inhibitors diminish LV dyssynchrony during the progression of pacing-induced HF, and beta-blocker therapy stimulates increases in local contractility and decreases in intraventricular dyssynchrony [6, 19]. The gene discussed is ACE; the disease is hydrops fetalis.